Jump to content

Advanced Therapy Medicinal Product

From Wikipedia, the free encyclopedia

Advanced Therapy Medicinal Products, or ATMPs, are advanced therapeutic drugs that are based on cell therapy or gene therapy (sometimes in combination with a medical device - where they are then called a tissue engineered product). The criteria to which a drug must conform to be classified as an ATMP, are defined in Article 17 of Regulation (EC) No 1394/2007 by the European Commission.[1]

References

[edit]
  1. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-20. Retrieved 2020-11-01.{{cite web}}: CS1 maint: archived copy as title (link)